| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/02/1997 | CN1034391C Preparation for intravaginal devices |
| 04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
| 03/28/1997 | CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010712A1 Inhibition of tumor necrosis factor alpha |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/26/1997 | EP0764204A1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 03/26/1997 | EP0764021A1 Uterine fibroid treatment |
| 03/26/1997 | CN1146202A Quinolone derivative for treatment of urinary incontinence |
| 03/26/1997 | CN1145899A Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound |
| 03/26/1997 | CN1145896A New alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 03/25/1997 | US5614208 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | WO1997009980A1 Pharmaceutical formulations containing darifenacin |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/19/1997 | EP0763035A1 Endothelin receptor antagonists |
| 03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
| 03/19/1997 | CN1145360A Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 03/19/1997 | CN1145241A Chronic nephritis pills |
| 03/19/1997 | CN1145223A Endothelin receptor antagonists |
| 03/18/1997 | US5612360 Aromatic n-heterocyclic compounds as hypotensive agents with acid groups, sulfonylcarboxamides or tetrazole groups |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612351 Azabicyclic derivatives of 1,2,3-oxa(or thia)diazole |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612320 Blends of dextrose, dextrin, maltodextrin with water |
| 03/18/1997 | US5612314 Nitrosylated neuropeptides |
| 03/13/1997 | WO1997009348A2 Orphan receptor |
| 03/13/1997 | WO1997009311A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |
| 03/13/1997 | WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract |
| 03/13/1997 | WO1997002826A3 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 03/13/1997 | WO1996040085A3 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 03/13/1997 | WO1996039372A3 Macrophage lipid chemoattractant |
| 03/12/1997 | EP0761684A2 Alanine substitution analogues of magainin peptides |
| 03/12/1997 | EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760668A1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/12/1997 | EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 03/12/1997 | EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 03/12/1997 | EP0422100B1 11 beta-substituted progesterone analogs |
| 03/12/1997 | CN1145075A Antagonist's of endothelin receptors |
| 03/12/1997 | CN1145027A Use of insulin sensitisers for treating renal diseases |
| 03/12/1997 | CN1144802A Pyridazinone derivatives and processes for preparing the same |
| 03/12/1997 | CN1144801A Beta-Adrenergic agonists |
| 03/12/1997 | CN1144800A 3-substituted oxindole derivatives as potassium channel modulators |
| 03/11/1997 | US5610167 Methods of inhibiting atrophy of the skin and vagina |
| 03/11/1997 | US5610153 Benzazepinone derivatives |
| 03/11/1997 | US5610138 Mixture of gonadotrophins and growth hormone |
| 03/11/1997 | US5610136 Administering chorionic gonadotropin |
| 03/11/1997 | CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels |
| 03/06/1997 | WO1997008166A1 Piperazino derivatives as neurokinin antagonists |
| 03/06/1997 | WO1997008144A1 Substituted benzylaminopiperidine compounds |
| 03/06/1997 | WO1997007796A1 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | CN1144486A Treatment of ovarian estrogen dependent conditions |
| 03/05/1997 | CN1144485A Adhesion inhibiting composition |
| 03/05/1997 | CN1034171C 4-pyrimdinone derivatives, their preparation and their application in therapy |
| 03/04/1997 | US5607978 Prostaglandins for vision defects |
| 03/04/1997 | US5607934 Preventing and treating diseases caused by superoxide radicals, nephritis |
| 02/27/1997 | WO1997006826A1 Gene therapy using ovine adenoviral vectors |
| 02/27/1997 | WO1996022095A3 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 02/27/1997 | DE19531067A1 Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität Use of boswellic acid and its derivatives for the inhibition of the normal and increased Leukozytenelastase- or plasmin |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 02/26/1997 | EP0758894A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 02/26/1997 | EP0705266B1 Process for producing imidazole derivative |
| 02/26/1997 | CN1143967A Method for variation of chromatin condensation |
| 02/26/1997 | CN1143963A Tetracyclic derivatives, process of preparation and use |
| 02/26/1997 | CN1143908A Treatment of diabetic nephropathy with valsartan |
| 02/26/1997 | CN1143644A N-|(1,4-diazadicyclo |2,2,2¨ oct -2-yl methyl¨ benzoic amide derivatives, its preparing process and medicinal use |
| 02/26/1997 | CN1034123C Calcium channel blocking polypeptides from filistate hibernalis |
| 02/25/1997 | US5606062 Stereoselective reduction |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605929 Methods and compositions for inhibiting 5α-reductase activity |
| 02/25/1997 | US5605909 Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds |
| 02/25/1997 | CA2030396C 5-[1-(imidazol)methyl]-3,3-disubstituted-2(3h)furanone derivatives |
| 02/25/1997 | CA1338940C Ó,ó-disubstituted n-cycloalkylalkylbenzylamines, process for their preparation, their use as a medicament and their synthesis intermediates |
| 02/20/1997 | WO1997006136A1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof |
| 02/20/1997 | WO1997005892A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | WO1997005876A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases |
| 02/20/1997 | WO1997005865A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2229098A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2228650A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | CA2228314A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases |
| 02/20/1997 | CA2227912A1 Benzenesulphonamide derivatives, their preparation and their application in therapy |
| 02/19/1997 | EP0758650A1 Endothelin receptor antagonists |
| 02/19/1997 | EP0758648A1 Substituted 4H-pyrans with a modulating effect on calcium channels |
| 02/19/1997 | EP0758644A1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758234A1 Method and composition for treating renal disease and failure |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines |
| 02/18/1997 | US5604261 Having hydroxyl/alkoxyl group ortho to amide group on phenyl ring; high melatonin receptor affinity |
| 02/18/1997 | US5604248 Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 02/18/1997 | US5604236 Beta-carboline thromboxane synthase inhibitors |